Delaware, US – Net sales of $5.8bn at Chemours in 2024 were down 4.9% on the $6.1bn achieved in 2023, with factors affecting the total including a 4% decrease in prices, and a further 1% decrease as a result of portfolio changes made during the year. Adjusted EBITDA fell by 22.5%, declining from $1.0bn last year to $786m this. It achieved net income of $86m, in a turnaround from the $238m loss made the year before.
In the fourth quarter, sales were up 2.6%, from 2023’s $380m to $390m in last year’s quarter. Adjusted EBITDA was essentially flat at $123m. A decrease of 3% in pricing was partially offset by a 2% increase in volume; the company made a net loss of $8m in the quarter, compared to $18m the year before.
The company’s thermal and specialized solutions business achieved record quarterly sales of $390m in Q4, up 2.6% on the previous year’s quarter. Volume growth was driven by stronger demand for Opteon refrigerants. Adjusted EBITDA for the segment fell 0.8% in the quarter, from $124m to $123m, with the decline primarily driven by lower prices, partially offset by lower costs.
